At Piel Eterna, we frequently receive inquiries from professionals and aesthetic centers wishing to acquire botulinum toxin (Botox®) through us. We appreciate that trust, but it is important to clarify that we cannot sell this type of product, neither legally nor on ethical grounds. The reason? Botox is not a common medical device: it is a highly regulated medication.
Although Botox is one of the most requested treatments in facial aesthetics, its acquisition is strictly regulated. In Spain, it can only be supplied by authorized pharmacies and under medical prescription. At Piel Eterna, we strictly comply with current legislation to ensure the safety and trust of our patients.
In this article, we clearly and simply explain why medical product distributors cannot sell Botox, what the law says in Spain, and who is authorized to acquire and administer this treatment.
1. Botox is a medication, not a medical device
Unlike other materials used in aesthetics, botulinum toxin type A is classified as a hospital-use medication. This means its regulation is much stricter: its distribution, storage, and administration are controlled by national and international health agencies, such as the AEMPS (Spanish Agency of Medicines and Medical Devices).
2. It requires a medical prescription and individualized prescription
The sale of Botox is limited exclusively to hospital pharmacies or authorized services. Only duly qualified and accredited physicians can prescribe and administer the product, following a clinical evaluation of the patient. Therefore, no distributor, regardless of their experience with aesthetic products, can offer Botox to the public or clinics without the corresponding prescription.
3. What does the legislation say in Spain?
In Spain, botulinum toxin is considered a restricted-use medication that can only be legally acquired through an authorized pharmacy, and only when there is an individualized medical prescription.
The supply to medical centers or healthcare professionals must be done through the established pharmaceutical channels. The AEMPS and regional health authorities actively monitor compliance with this regulation. Purchasing botulinum toxin outside these channels may result in administrative and even criminal penalties.
4. Legal and safety risks
Selling Botox without a license or outside the authorized pharmaceutical channel is illegal and can lead to very serious sanctions for both the seller and the professional who acquires it. Additionally, buying Botox through unregulated channels endangers patient health, as traceability, preservation, and authenticity of the product cannot be guaranteed.
5. The European regulatory framework makes it clear
In Europe, the marketing of medications is subject to strict regulations. Distributors of medical products may sell materials classified as “medical devices,” but not pharmaceuticals, which include botulinum toxin. This is clearly specified in Regulation (EU) 2017/745 on medical devices and in the pharmaceutical legislation of each member country.